Acadia Pharma (ACAD) Misses Q2 EPS by 14c
Tweet
Share
E-mail
Get Alerts ACAD Hot Sheet
Price: $30.18 +4.03%
Financial Fact:
Collaborative revenues: 5.27M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Collaborative revenues: 5.27M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Acadia Pharma (NASDAQ: ACAD) reported Q2 EPS of ($0.63), $0.14 worse than the analyst estimate of ($0.49). Revenue for the quarter came in at $97 thousand versus the consensus estimate of $90 thousand.
For earnings history and earnings-related data on Acadia Pharma (ACAD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Jack Henry (JKHY) Tops Q4 EPS by 13c
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
